Abstract
Skin diseases are the fourth most common form of human disease and of these, eczema is the leading cause. Eczema often begins in infancy and its treatment and associated conditions, including psychological stress, contribute to a decreased quality of life for children and their families.
Eczema pathophysiology is complex and long-term management involves community-based care. Multidisciplinary approaches to paediatric eczema care, such as the National Allergy Strategy’s Shared Care Model for Allergic Diseases, blend the skills of a range of health professionals in a patient-centered approach to care. Community pharmacists are readily accessible members of the health care team and have contact with children with eczema and their carers at all stages of the disease.
The Paediatric Eczema Model of Care for Pharmacists (PEMCP) aims to provide the building blocks required for pharmacists to share in the delivery of the right care at the right time for children with eczema.
In 2021 and 2022, the PEMCP Expert Advisory Group was tasked to commence the development of a PEMCP for Western Australia. The group undertook an extensive process to analyse any innovations already in the field and consult with stakeholders to understand the current problem. This was used to define the change needed in how pharmacists care for children with eczema, and design a solution. The resulting proposed model of care identifies the elements required for pharmacists to deliver healthcare services for children with eczema and their carers. These elements are underpinned by three holistic principles:
• access to care
• consistency of care, and
• collaboration
To effectively support children with eczema, the proposed PEMCP identified that pharmacists require four core elements:
• education
• time
• an Eczema Action Plan, and
• defined referral pathways
These elements interact and combine to meet the holistic principles of access to care, consistency of care and collaboration. The PEMCP sits within the National Allergy Strategy Shared Care Model for Allergic Diseases.
Eczema pathophysiology is complex and long-term management involves community-based care. Multidisciplinary approaches to paediatric eczema care, such as the National Allergy Strategy’s Shared Care Model for Allergic Diseases, blend the skills of a range of health professionals in a patient-centered approach to care. Community pharmacists are readily accessible members of the health care team and have contact with children with eczema and their carers at all stages of the disease.
The Paediatric Eczema Model of Care for Pharmacists (PEMCP) aims to provide the building blocks required for pharmacists to share in the delivery of the right care at the right time for children with eczema.
In 2021 and 2022, the PEMCP Expert Advisory Group was tasked to commence the development of a PEMCP for Western Australia. The group undertook an extensive process to analyse any innovations already in the field and consult with stakeholders to understand the current problem. This was used to define the change needed in how pharmacists care for children with eczema, and design a solution. The resulting proposed model of care identifies the elements required for pharmacists to deliver healthcare services for children with eczema and their carers. These elements are underpinned by three holistic principles:
• access to care
• consistency of care, and
• collaboration
To effectively support children with eczema, the proposed PEMCP identified that pharmacists require four core elements:
• education
• time
• an Eczema Action Plan, and
• defined referral pathways
These elements interact and combine to meet the holistic principles of access to care, consistency of care and collaboration. The PEMCP sits within the National Allergy Strategy Shared Care Model for Allergic Diseases.
Original language | English |
---|---|
Place of Publication | Australia |
Publisher | The University of Western Australia |
Commissioning body | Perth Children's Hospital Foundation |
Number of pages | 36 |
Publication status | Published - 8 Aug 2022 |